Press release
Impact BioMedical Inc. (NYSEAmerican: IBO): Targeting Chronic Diseases with Patented Breakthrough
Chronic inflammatory diseases, identified by the World Health Organization as the leading global health threat, are a key focus area. Recent estimates reveal nearly 60% of Americans live with at least one chronic condition, and three out of five deaths worldwide result from diseases like cancer, diabetes, and respiratory disorders. This urgent need for solutions presents immense opportunities for innovation.
In this rapidly evolving landscape, Impact BioMedical Inc. (NYSEAmerican: IBO) emerges as a promising player committed to advancing healthcare innovation.
A Promising Player in Biotech
Impact BioMedical Inc. (NYSEAmerican: IBO), a pioneering biotechnology firm, has quickly captured attention since its IPO in September 2024. Focused on discovering, developing, and patenting innovative solutions for human healthcare and wellness, the company is building momentum as it positions itself to address unmet medical needs in various fields.
A Strong Start: The IPO and Investor Confidence
On September 16, 2024, Impact BioMedical entered the public market with its initial public offering of 1.5 million shares priced at $3.00 each. The IPO, which raised $4.5 million, garnered robust interest, with over 30% of shares purchased by existing investors. This strong participation signals significant confidence in the company's potential and direction.
Impact BioMedical CEO Frank D. Heuszel commented on the IPO's success, emphasizing that investor confidence reflects the belief in the company's mission to deliver transformative healthcare solutions.
Leadership Positioned for Growth
At the helm of Impact BioMedical is a highly experienced leadership team. CEO Frank D. Heuszel, with a background in finance and executive leadership, has been instrumental in guiding the company's strategic direction. Heuszel's tenure as CEO of DSS, Inc., Impact BioMedical's parent company, since 2019 has prepared him to navigate the complexities of biotech innovation and commercialization.
Supporting Heuszel is COO Mark Suseck, who brings extensive experience in strategy, licensing, and acquisitions from his time at DSS BioHealth Holdings and Vivacitas Oncology. CFO Todd Macko complements the team with his expertise in financial planning, analysis, and mergers and acquisitions, ensuring the company is fiscally sound as it expands.
Together, this leadership team aims to drive innovation and establish Impact BioMedical as a key player in the biotechnology sector.
Innovative Technology Platforms with Real-World Applications
Impact BioMedical is built on a foundation of cutting-edge technologies designed to tackle pressing healthcare challenges. Two standout platforms, 3F and Linebacker, highlight the company's unique approach to improving human health and wellness.
The 3F insect repellent technology recently secured a U.S. patent, showcasing its potential as a natural solution to reduce insect landings and bites. Unlike chemical-based alternatives, 3F uses plant-derived formulations to effectively "blind" insects to human presence. Its applications range from standalone repellents to integrations in shampoos and detergents. With vector-borne diseases accounting for 17% of infectious diseases globally, 3F addresses a significant market need. CEO Frank Heuszel emphasized the company's commitment to advancing commercialization efforts with potential partners, aiming to provide eco-friendly solutions for outdoor safety.
Another major achievement is the Canadian patent for Linebacker technology, which targets inflammatory diseases with novel phenolic compounds. This platform offers potential relief for conditions such as arthritis, asthma, and inflammatory bowel disease, while mitigating the side effects associated with traditional treatments. Derived from myricetin, a plant-based flavonoid, Linebacker compounds are designed to inhibit inflammatory responses and oncogenic pathways. The technology has been licensed to ProPhase Laboratories for global development and commercialization, paving the way for promising revenue opportunities.
Expanding IP Portfolio
Impact BioMedical's ability to secure patents across jurisdictions underscores its commitment to innovation and its potential for market leadership. The company's IP portfolio includes patents for insect repellent compositions and inflammatory disease treatments in the U.S., Canada, and other regions, providing a strong competitive edge.
The Road Ahead
As a relatively new public entity, Impact BioMedical has already demonstrated an ability to attract investor confidence, build a robust IP portfolio, and establish partnerships for product development. The company's technologies address critical health challenges, offering significant market potential in both developed and emerging markets.
Conclusion
Impact BioMedical (NYSEAmerican: IBO) is emerging as a promising force in biotechnology. With its focus on innovative healthcare solutions, a strong leadership team, and a growing IP portfolio, the company could be well-positioned for long-term growth. Impact BioMedical's strategic initiatives and commitment to innovation offer a compelling case for investors looking to tap into the potential of healthcare advancements.
Disclaimers: RazorPitch Inc. "RazorPitch" is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performances are not statements of historical fact and may be forward-looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements in this action may be identified through the use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the companies profiled. RazorPitch has been retained and compensated by Cambridge Consulting to assist in the production and distribution of this content. RazorPitch is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only; you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by RazorPitch or any third-party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. RazorPitch is not a fiduciary by virtue of any persons use of or access to this content.
Media Contact
Company Name: RazorPitch
Contact Person: Mark McKelvie
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=impact-biomedical-inc-nyseamerican-ibo-targeting-chronic-diseases-with-patented-breakthrough]
City: NAPLES
State: Florida
Country: United States
Website: https://razorpitch.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Impact BioMedical Inc. (NYSEAmerican: IBO): Targeting Chronic Diseases with Patented Breakthrough here
News-ID: 3741540 • Views: …
More Releases from ABNewswire
AI-Powered Santa Videos Turn Screens Into Real Christmas Magic for Families This …
As families look for more meaningful, screen-based traditions, LiveImage AI is transforming how children experience Santa Claus with personalized AI-powered Santa video messages that feel like they're straight from the North Pole.
Last year, LiveImage AI produced over 1,200 customized Santa video [https://liveimage.ai/santa] messages, each uniquely tailored to the child who received it. Parents reported that these videos became an instant holiday ritual-played on repeat, shared with grandparents, and saved as…
Vincent Clinic Unveils New Insights on Treatments and Their Role in Enhancing Lo …
Because of how easy it is and how quickly the results come in, Bangkok has become a number 1 destination for those seeking out botox and cosmetic procedures. Most people don't aim to change their appearance; they want softer, smoother, more expressive skin.
If you want to preserve the longevity of the cosmetic results, having some background knowledge in longevity and choosing the right provider for Botox Bangkok [https://vincent.clinic/en/service/detail/botox] is very…
Vincent Clinic Shares Essential Tips to Help Clients Get the Most Out of Their A …
There is no denying that Botox and other non-surgical cosmetic treatments have gained enormous popularity. Thanks to the first-rate medical esthetics clinics, acquiring these services in Bangkok is a walk in the park. Regardless, to make that expensive cost worthwhile, it is essential to learn how to get the most out of your Botox treatment.
Getting Botox is a rather uncomplicated and straightforward procedure to complete, and that typically leaves first-timers…
In a crowded luxury villa space, Haute Retreats is quietly rewriting the rules
Image: https://www.abnewswire.com/upload/2025/11/14b1e262b39b5573183045cbcf5cb7b2.jpg
When the sun rises over Anguilla's Meads Bay, the island is almost disarmingly still. The surf is soft, the palm trees barely move, and the only real commotion is inside one of the low-slung villas tucked discreetly above the sand. A private chef is plating breakfast for a family that has, by design, nowhere they urgently need to be: calls taken from a shaded terrace, teenagers drifting between the…
More Releases for Impact
Chatbot Market Impact of Industry Size, and Impact Y-o-Y
The Global Chatbot Market size accounted for USD 521 Million in 2021 and is expected to reach USD 3,411 Million by 2030 growing at a CAGR of 23.7% during the forecast period from 2022 to 2030.
Global Chatbot Market Growth Aspects
The rising emphasis on consumer participation through numerous mediums around the world is one of the key factors driving the growth of the chatbots industry. Businesses' greater usage of customer service…
Technological Impact: Circuit Breaker Market Development Amid the COVID-19 Impac …
The apocalypse of COVID-19 disease has negatively affected the global market for the circuit breaker during the projected period. This pandemic spread has created a severe impact on the operational process of businesses across the world. Contrary to this, though most of the countries have implemented total lockdown in order to prevent the communal spread of the disease, the circuit breaker market shall have a significant growth due to rapidly…
Covid-19 Impact On Impact Modifier Market Research Report 2019-2029.
This FMI study offers a ten-year analysis and forecast for the global impact modifier market between 2018 and 2028. The study considers 2017 as the base year with market values estimated for 2018 and a forecast developed for the duration between 2019 and 2028. Compound Annual Growth Rate (CAGR) is represented from 2018 to 2028. The study covers various perspectives of the impact modifiers market, including market dynamics, value chain,…
High Impact PolyStyrene Market Current Impact to Make Big Changes 2020
"MARKET GROWTH INSIGHT information of the Global High Impact PolyStyrene Market report will surely grow business and improve return on investment (ROI). The report is ready to refer to documents that share important details of the market from a historical point of view, allowing readers to measure concurrent developments to make accurate growth speculations and forecast assessments. The report provides an exclusive overview of the competitive spectrum to identify major…
Analysis of Potential Impact of COVID-19 on Impact Modifier Market
Global Impact Modifier Market: Overview
The growth of the global impact modifier market has gathered pace, owing to the pivotal use of impact modifier in construction processes and automotive industries. Impact modifiers are a group of additives which help in enhancing the strength of polymer compounds. They are available in the form of resins and imparts rubbery nature. This elastic nature of impact modifier increases the durability of polymer compounds when…
Stain Removers Market Research Report (COVID-19) IMPACT 2020 with Coronavirus Im …
This has brought along several changes in This report also covers the impact of COVID-19 on the global Stain Removers market.
The Stain Removers Market analysis summary by Reports Insights is a thorough study of the current trends leading to this vertical trend in various regions. Research summarizes important details related to market share, market size, applications, statistics and sales. In addition, this study emphasizes thorough competition analysis on market prospects,…
